Showing results (611-620 of 5,988) with videos related to

Sort By:
Pageof 599
Molecular Psychiatry|April 30, 2009
High-density SNP association study and copy number variation analysis of the AUTS1 and AUTS5 loci implicate the IMMP2L-DOCK4 gene region in autism susceptibilityE Maestrini, A T Pagnamenta, J A Lamb, et al.
Molecular Psychiatry|January 7, 2009
Variations in tryptophan hydroxylase 2 linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depressionS Kloiber, M A Kohli, T Brueckl, et al.
Molecular Psychiatry|January 7, 2009
Examination of the current top candidate genes for AD in a genome-wide association studyT M Feulner, S M Laws, P Friedrich, et al.
Molecular Psychiatry|January 14, 2009
Ageing abolishes the effects of fluoxetine on neurogenesisS Couillard-Despres, C Wuertinger, M Kandasamy, et al.
Molecular Psychiatry|January 14, 2009
Proteomic-based genotyping in a mouse model of trait anxiety exposes disease-relevant pathwaysC Ditzen, J Varadarajulu, L Czibere, et al.
Molecular Psychiatry|October 15, 2008
Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicityM Verhagen, A van der Meij, P A M van Deurzen, et al.
Molecular Psychiatry|March 26, 2004
Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635Z Bhagwagar, E A Rabiner, P A Sargent, et al.
Molecular Psychiatry|July 28, 2004
Glutamate as a therapeutic target in psychiatric disordersD C Javitt
Molecular Psychiatry|September 2, 2004
MR-based in vivo hippocampal volumetrics: 1. Review of methodologies currently employedE Geuze, E Vermetten, J D Bremner
Molecular Psychiatry|October 27, 2004
Separate and interacting effects within the catechol-O-methyltransferase (COMT) are associated with schizophreniaH Y Handoko, D R Nyholt, N K Hayward, et al.
Pageof 599